| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.2M | — | -18.3% |
| Cost of Revenue | $9.4M | — | -13.7% |
| Gross Profit | $3.8M | — | -27.8% |
| R&D Expense | $1.0M | — | -21.1% |
| SG&A Expense | $4.9M | — | -4.1% |
| Operating Income | -$2.2M | — | -79.7% |
| Net Income | -$2.6M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.6M | +19.0% | +184.1% |
| Accounts Receivable | $7.5M | -34.1% | -24.6% |
| Inventory | $15.7M | -8.7% | +2.5% |
| Current Assets | $27.0M | -15.2% | +0.4% |
| Total Assets | $29.7M | -14.6% | -3.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $889K | — | -5.8% |
| Capital Expenditures | $163K | — | -17.7% |
| Investing Cash Flow | -$163K | — | +17.7% |
| Financing Cash Flow | -$472K | — | +43.1% |
| Free Cash Flow | $726K | — | -2.7% |
| -53.5% |
| EPS (Basic) | -$0.15 | — | -50.0% |
| EPS (Diluted) | -$0.15 | — | -50.0% |
| $32.2M |
| -18.8% |
| +5.4% |
| Total Liabilities | $33.0M | -17.8% | +4.1% |
| Stockholders' Equity | -$3.3M | +38.6% | -194.3% |